Profile
Mythili Koneru currently works at Legend Biotech Corp., as Chief Medical Officer from 2023.
Dr. Koneru also formerly worked at Eli Lilly & Co., as Senior Medical Director-Early Phase Clinical and Marker Therapeutics, Inc., as Chief Medical Officer from 2019 to 2023.
Dr. Koneru received her undergraduate degree from The University of Chicago, doctorate degree from New York University, and doctorate degree from Robert Wood Johnson Medical School.
Mythili Koneru active positions
| Companies | Position | Start |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Chief Tech/Sci/R&D Officer | 2023-04-10 |
Former positions of Mythili Koneru
| Companies | Position | End |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-04-08 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2019-01-31 |
Training of Mythili Koneru
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Marker Therapeutics, Inc.
Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Medical School
Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Legend Biotech Corp.
Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
- Stock Market
- Insiders
- Mythili Koneru
















